Insulin-Like Growth Factor-I and High Protein Diet Decrease Calpain-Mediated Proteolysis in Murine Muscular Dystrophy

Experimental Biology and Medicine

Volumn 218, Issue 3, 1998, Pages 244-250

  Wingertzahn, Mark A ^a   Zdanowicz, Martin M ^b   Slonim, Alfred E ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; RECOMBINANT SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HORMONE ACTION; MALE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DIET;

ANIMALS; BLOTTING, WESTERN; CALPAIN; CATHEPSIN B; DIETARY PROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, MUTANT STRAINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; RECOMBINANT PROTEINS; UBIQUITINS;

ANIMALIA; MURINAE;

EID: 0031842735     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-218-44294     Document Type: Article

References (40)

1. Goldberg AL, Griffin GE, Dice JF. Regulation of protein synthesis in normal and dystrophic muscle. In: Rowland LP, Ed. Pathogenesis of Human Muscular Dystrophies. Amsterdam: Excerpta Medica, pp 191-194, 1977.
2. Furono K, Goodman MN, Goldberg AL. Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem 265:8550-8557, 1990.
3. Cooney RN, Kimball SR, Vary TC. Regulation of skeletal muscle protein turnover during sepsis: Mechanisms and mediators. Shock 7:1-16, 1997.
4. Bhattacharyya J, Thompson K, Sayeed MN. Calcium-dependent and calcium-independent activities in skeletal muscle during sepsis. Circulation Shock 35:117-122, 1991.
5. Thompson HS, Scordilis SP. Ubiquitin changes in human biceps muscle following exercise-induced damage. Biochem Biophys Res Commun 204:1193-1198, 1994.
6. Ashmore CR, Summers PJ, Lee YB. Proteolytic enzyme activities and onset of muscular dystrophy in the chick. Exp Neurol 94:585-597, 1986.
7. Johnson P. Calpain and calpastatin levels in dystrophic hamster skeletal muscles. Im J Biochem Cell Biol 20:1227-1230, 1988.
8. Takeda A, Jimi T, Wakayama Y, Misugi N, Miyake S, Kumgai T. Demonstration of cathepsins B, H, and L in xenografts of normal and Duchenne muscular dystrophy muscle transplanted into nude mice. Biochem J 288:643-648, 1992.
9. Zdanowicz MM, Moyse J, Wingertzahn M, O'Connor M, Teichberg S, Slonim AE. Effect of insulin-like growth factor I in murine muscular dystrophy. Endocrinology 136:4880-4886, 1995.
10. Zdanowicz MM, Slonim AE, Bilaniuk I, O'Connor M, Moyse J, Teichberg S. Beneficial effects of high protein diet in murine muscular dystrophy. J Nutr 125:1150-1158, 1995.
11. Zdanowicz MM, Teichberg S, Moyse J, O'Connor M, Slonim AE. Metabolic and structural effects of IGF-I and high protein diet on dystrophic hamster skeletal muscle. Proc Soc Exp Biol Med 215:168-173, 1997.
12. Goodman M, Gomez M. Decreased myofibrillar proteolysis after refeeding requires dietary proteins or amino acids. Am J Physiol 253:E52-E58, 1987.
13. Wong PWK, O'Flynn ME, Inouye T. Micromethods for measuring phenylalanine and tyrosine in serum. Clin Chem 10:1098-1104, 1964.
14. Barret AJ, Kirschke H, Cathepain B, cathepsin H, and cathepsin L. Methods Enzymol 80:535-561, 1981.
15. Moss D, Guiterrez Y, Perez R, Kobayashi H. Simple spectrophotometric assay for calcium-activated neutral proteases (calpains). Pharmacol Biochem Behav 39:495-497, 1991.
16. Garcia-Martinez C, Agell N, Llovera M, Lopez-Soriano FJ, Argiles JM. Tumor necrosis factor-2 increases ubiquitinization of rat skeletal muscle proteins. FEBS Lett 323:211-214, 1993.
17. Haas AL, Siepmann TJ. Pathways of ubiquitin conjugation. FASEB J 11:1257-1268, 1997.
18. Zar JH. Multisample Hypothesis. In: Kurtz B, Ed. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, pp162-183, 1984.
19. Spencer MJ, Tidball JG. Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin deficient muscle. Exp Cell Res 203:107-114, 1992.
20. Rabbani N, Moses C, Anadaraj MPJS. Calcium-activated neutral protease and its endogenous inhibitor in tissues of dystrophic and normal mice. Biochem Med Metab Biol 37:282-286, 1987.
21. Reddy PA, Anadavalli TE, Anadaraj MPJS. Calcium-activated neutral proteases and endogenous CANP inhibitor of muscle in Duchenne muscular dystrophy (DMD). Clin Chim Acta 160:281-282, 1986.
22. Takagi A, Kojima S, Ida M, Araki M. Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse. J Neurol Sci 110:160-164, 1992.
23. Xu H, Christmas P, Wu X, Wewer U, Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA 91:5572-5576, 1994.
24. Nakamyra M, Imajoh-Ohumi S, Suzuki K, Kawashima S. An endogenous inhibitor of calcium-activated neutral protease in UMX 7.1 hamster dystrophy. Muscle Nerve 14:701-708, 1991.
25. Lowell BB, Ruderman WB, Goodman MN. Evidence that lysosomes are not involved in the degradation of proteins in rat skeletal muscle. Biochem J 234:237-240, 1986.
26. Askansas K, Serdaroglu P, Engel N, Alvarez R. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and occulopharyngeal muscular dystrophy. Neurosci Lett 130:73-76, 1991.
27. Wing SS, Haas AL, Goldberg, AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 307:639-645, 1995.
28. Medina R, Wing SS, Goldberg AL. Increase in levels of polyubiquitin and proteosome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem J 307:631-637, 1995.
29. Fulks RM, Li JB, Goldberg AL. Effect of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem 250:290-298, 1975.
30. Clemmons DR, Smith-Banks A, Celinker AC. Reversal of diet-induced catabolism by infusion of recombinant IGF-I in humans. J Clin Endocrinol Metab 74:142-147, 1992.
31. Clemmons DR, Underwood LE. Role of insulin-like growth factors and growth hormone in reversing catabolic states. Horm Res 38:37-40, 1992.
32. Dunn AD, Myers HE, Dunn JT. The combined action of two thyroidal proteases releases T4 from dominant hormone-forming site of thyroglobulin. Endocrinology 137:3279-3285, 1996.
33. Dunn AD, Dunn JT. Cysteine proteinases from human thyroids and their actions on thyroglobulin. Endocrinology 123:1089-1097, 1997.
34. Goldberg AL, Tischler M, DeMartino G, Grifin G. Hormonal regulation of protein synthesis and degradation in skeletal muscle. Fed Proc 39:30-37, 1980.
35. Kargacin ME, Kargacin GJ. The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle. Biochim Biophys Acta 1290:4-8, 1996.
36. Takagi A, Kojima S, Ida M, Araki M. Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse. J Neurol Sci 110:160-164, 1992.
37. Slonim AE, Coleman RA, Moses WS. Myopathy and growth failure in debrancher enzyme deficiency: Improvement with high-protein nocturnal enteral therapy. J Pediatr 105:906-911, 1984.
38. Slonim AE, Coleman RA, McElligot MA, Najjar J, Hirschhorn K, Labadie GU, Mrak R, Evans OB, Shipp E, Presson R. Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology 33:34-38, 1983.
39. Slonim AE, Weisberg C, Benke P, Evans OB, Burr IM. Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11:420-422, 1982.
40. Cangiao C. Effects of oral branched-chain amino acid administration in the treatment of cancer cachexia. Clin Res 42:129A, 1994.